FDA Clear On Supplement Ingredient Petitions, But Still Fuzzy On Sec. 912
This article was originally published in The Tan Sheet
Executive Summary
FDA says current dietary supplement regulations make clear that citizen petitions can be filed to request approval of ingredients that were studied in clinical trials and were part of unsuccessful investigational new drug applications